Who owns 4D Molecular Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of FDMT from SEC Form 13F filings across 157 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 157 institutions disclosed 58.0M shares of 4D Molecular Therapeutics, Inc. worth $771.2M — about 82.6% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
157
13F holders
$771.2M
value, 2026 filers
82.6%
of shares outstanding (58.0M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of FDMT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 5.7M | $76.5M | 0.0% | 8.2% | new |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 5.0M | $67.2M | 0.6% | 7.2% | 0.0% |
| 3 | BlackRock, Inc. | 4.5M | $60.5M | 0.0% | 6.5% | +9.7% |
| 4 | GOLDMAN SACHS GROUP INC | 4.3M | $56.6M | 0.0% | 6.1% | +1.3% |
| 5 | NOVO HOLDINGS A/S | 3.2M | $43.2M | 2.5% | 4.6% | -11.0% |
| 6 | STATE STREET CORP | 2.9M | $38.7M | 0.0% | 4.1% | +7.5% |
| 7 | BVF INC/IL | 2.9M | $38.3M | 1.0% | 4.1% | 0.0% |
| 8 | T. Rowe Price Investment Management, Inc.NEW | 2.5M | $33.4M | 0.0% | 3.6% | new |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.2M | $29.9M | 0.0% | 3.2% | +40.1% |
| 10 | Trails Edge Capital Partners, LP | 2.2M | $29.6M | 4.7% | 3.2% | +71.0% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 2.1M | $27.9M | 0.0% | 3% | new |
| 12 | ARMISTICE CAPITAL, LLC | 2.0M | $26.6M | 0.3% | 2.8% | 0.0% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $15.0M | 0.0% | 1.6% | +5.9% |
| 14 | BANK OF AMERICA CORP /DE/ | 1.1M | $14.9M | 0.0% | 1.6% | +15.0% |
| 15 | Evergreen Quality Fund GP, Ltd. | 951,474 | $12.7M | 0.2% | 1.4% | 0.0% |
| 16 | Parkman Healthcare Partners LLC | 948,184 | $12.6M | 1.3% | 1.3% | +81.4% |
| 17 | DIMENSIONAL FUND ADVISORS LP | 730,857 | $9.7M | 0.0% | 1% | +39.8% |
| 18 | DEUTSCHE BANK AG\ | 710,942 | $9.5M | 0.0% | 1% | +0.4% |
| 19 | CITADEL ADVISORS LLC | 687,597 | $9.1M | 0.0% | 1% | +160.4% |
| 20 | RENAISSANCE TECHNOLOGIES LLC | 614,573 | $8.2M | 0.0% | 0.9% | +6.3% |
| 21 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 579,903 | $7.7M | 0.0% | 0.8% | new |
| 22 | DIADEMA PARTNERS LPNEW | 571,107 | $7.6M | 1.0% | 0.8% | new |
| 23 | NORTHERN TRUST CORP | 562,929 | $7.5M | 0.0% | 0.8% | +64.6% |
| 24 | ACUTA CAPITAL PARTNERS, LLCNEW | 507,801 | $6.8M | 4.7% | 0.7% | new |
| 25 | Nuveen, LLC | 503,071 | $6.7M | 0.0% | 0.7% | -10.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.